Mumbai: In order diversify its fund portfolio, UTI Mutual Fund (MF) plans to introduce an overseas fund that will invest up to 65 percent of its corpus in emerging market securities. This announcement came from U.K. Sinha, Chairman and Managing Director of UTI Asset Management Company (AMC) during an event held to close T. Rowe Price's acquisition of 26 percent stake in UTI AMC. T. Rowe Price is a U.S. based investment manager, which now becomes the largest shareholder in the company after the deal. The 26 percent stake will give also T. Rowe Price a representation on the UTI MF Board. Two representatives of T. Rowe Price will be inducted on the board now, said Sinha. The strategic tie-up will not involve any change in the fund manager profile at UTI. However, Sinha says that T Rowe Price's expertise would be brought in for UTI's pension fund management. The Baltimore-based T Rowe Price Group had bought 26 percent stake in UTI AMC last November for 2,500 crore. "Our marketing and sales force and technology and operations teams are meeting with the UTI team to chart out business strategies for the future," said James A.C. Kennedy, Chief Executive Officer, and President of T. Rowe Price Group.